US Patent 10669277 Inhibitors of activin receptor-like kinase
Patent 10669277 was granted and assigned to Blueprint Medicines on June, 2020 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
March 5, 2019
0
Date of Patent
June 2, 2020
0
Patent Applicant
Patent Application Number
16293317
0
Patent Citations
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 10669277 Inhibitors of activin receptor-like kinase
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
